Get Ready for a Biotech M&A Comeback
RBC Capital, heartened by some billion-dollar-plus deals, sees a new buyout hunger in Big Pharma.
Companies, tightfisted on payouts since last year’s market wipeout, feel flush now, Credit Suisse says.
Alan Martinovich, with global management consultancy Arthur D. Little, says now is the time to make intentional moves that will drive green transformation.